|
IWS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.285600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.715200E-01 |
| Normal-vs-Stage2 |
4.589000E-01 |
| Normal-vs-Stage3 |
8.232600E-01 |
| Normal-vs-Stage4 |
9.025800E-01 |
| Stage1-vs-Stage2 |
1.237230E-01 |
| Stage1-vs-Stage3 |
2.099400E-01 |
| Stage1-vs-Stage4 |
2.583200E-01 |
| Stage2-vs-Stage3 |
6.313600E-01 |
| Stage2-vs-Stage4 |
5.384400E-01 |
| Stage3-vs-Stage4 |
9.204000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.523400E-01 |
| Normal-vs-AfricanAmerican |
2.084200E-01 |
| Normal-vs-Asian |
4.380600E-01 |
| Caucasian-vs-AfricanAmerican |
4.822200E-01 |
| Caucasian-vs-Asian |
7.668600E-01 |
| AfricanAmerican-vs-Asian |
6.605600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.736200E-01 |
| Normal-vs-Female |
7.038200E-01 |
| Male-vs-Female |
7.420400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.095390E-01 |
| Normal-vs-Age(41-60Yrs) |
5.965600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.154800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.092000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.778100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.940000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.678000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.420000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.941400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.849400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.539000E-01 |
| Classical-VS-Follicular |
1.68290000046589E-07 |
| Classical-VS-Other |
4.544800E-01 |
| Classical-VS-Normal |
4.633600E-02 |
| Tall-VS-Follicular |
7.892400E-02 |
| Tall-VS-Other |
8.914000E-01 |
| Tall-VS-Normal |
8.690400E-01 |
| Follicular-VS-Other |
3.916600E-01 |
| Follicular-VS-Normal |
1.332350E-02 |
| Other-VS-Normal |
9.506400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.197600E-01 |
| Normal-vs-N1 |
6.576400E-01 |
| N0-vs-N1 |
7.893200E-01 |
|
|
